SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-048733
Filing Date
2012-07-12
Accepted
2012-07-12 17:19:33
Documents
6
Period of Report
2012-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-16202_48k.htm 8-K 36156
2 EX-1.1 a12-16202_4ex1d1.htm EX-1.1 212770
3 EX-5.1 a12-16202_4ex5d1.htm EX-5.1 15929
4 EX-99.1 a12-16202_4ex99d1.htm EX-99.1 9962
5 GRAPHIC g162024kmi001.jpg GRAPHIC 2636
6 GRAPHIC g162024mmi001.gif GRAPHIC 2539
  Complete submission text file 0001104659-12-048733.txt   283341
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 12959848
SIC: 2834 Pharmaceutical Preparations